文献速递皮肤肿瘤

黑色素瘤诊断10年后晚期复发:病程是否不同于早期复发?

Late recurrence of melanoma after 10 years - Is the course of the disease different from early recurrences?
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-12-18

该回顾性研究分析了1537例黑色素瘤患者,其中1438例(93.6%)在10年内早期复发,99例(6.4%)在10年后晚期复发。晚期复发患者更年轻、溃疡更少、头颈部定位更少且肿瘤更薄,但两组黑色素瘤特异性生存时间几乎相同。多因素分析显示男性、躯干肿瘤定位、肿瘤厚度和溃疡是MSS的独立预后因素。

要点

  • 晚期复发(>10年)患者更年轻、肿瘤更薄、溃疡和头颈部定位更少。
  • 晚期与早期复发患者的黑色素瘤特异性生存时间无显著差异。
  • 男性、躯干定位、肿瘤厚度和溃疡是MSS的独立预后因素。

核心结论

  • 早期和晚期复发患者具有不同的临床病理特征,但首次复发时间似乎不影响生存。

研究设计与样本

  • 回顾性研究,纳入1537例黑色素瘤患者,晚期复发定义为首次诊断后10年及以上复发,早期复发定义为10年内复发。

主要发现

  • 早期转移发生于1438例(93.6%),晚期转移发生于99例(6.4%)。
  • 晚期复发患者更年轻(P < 0.001),溃疡更少(P = 0.005),头/颈部定位更少(P = 0.009),肿瘤更薄(P < 0.001)。
  • MSS时间(均值±SD)晚期复发为31±4.4个月(95% CI [22.3-39.7]),早期复发为32±1.9个月(95% CI [28.3-35.7]),两组几乎相同。
  • 多因素回归分析显示男性(HR = 1.4,P < 0.001)、躯干肿瘤定位(HR = 1.7,P < 0.001)、肿瘤厚度(HR = 1.4,P < 0.045)和溃疡(HR = 1.3,P < 0.008)是MSS的显著独立预后因素。

临床怎么用

  • 对于黑色素瘤患者,无论复发时间早晚,均应关注男性、躯干定位、肿瘤厚度和溃疡等预后因素。
  • 晚期复发患者虽临床病理特征不同,但生存结局与早期复发相似,提示复发时间不影响生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is known that melanoma can metastasize and recur many years after the first diagnosis. Although predictive and prognostic factors for melanoma are well defined, there is still insufficient information about the factors affecting the recurrence period and the effect of the recurrence time to survival. OBJECTIVES: This study investigates the course of melanoma to show prognostic factors comparing early and late recurrence patients. The main objective is to uncover the effect of the recurrence time on the progression of the disease. METHODS: In this retrospective study, late recurrence (LR) was defined as melanoma recurrence 10 years after the first diagnosis and early recurrence (ER) was defined as recurrence within 10 years. Gender, age, localization of primary tumour, time to first metastasis, survival rates, histological subtype, stage, tumour thickness, invasion level, ulceration and regression of the primary melanoma were documented. Survival curves were evaluated using the Kaplan-Meier and compared with the log-rank test. Multivariate Cox proportional hazard models were used to identify significant independent prognostic factors for melanoma-specific survival (MSS). RESULTS: A total of 1537 melanoma patients were analysed. Early metastasis was developed in 1438 patients (93.6%), and 99 patients (6.4%) developed late metastasis. Late recurrence patients were younger (P < 0.001) and had fewer ulcerated (P = 0.005), fewer head/neck localized (P = 0.009) and thinner (P < 0.001) melanomas than ER patients. The MSS time (mean ± SD) was nearly identical for LR (31 ± 4.4 months 95% CI [22.3-39.7]) and ER (32 ± 1.9 months [28.3-35.7]). Multivariate regression analysis revealed male gender (hazard ratio [HR = 1.4, P < 0.001), truncal tumour localization (HR = 1.7, P < 0.001), tumour thickness (HR = 1.4, P < 0.045) and ulceration (HR = 1.3, P < 0.008) as significant independent prognostic factors for MSS. CONCLUSION: Although ER and LR patients are found to have different clinicopathologic features, the time of the first recurrence after diagnosis do not seem to have an effect on the survival.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Sarac E, Wilhelmi J, Thomas I, et al. Late recurrence of melanoma after 10 years - Is the course of the disease different from early recurrences? J Eur Acad Dermatol Venereol. 2019. PMID: 31758713. doi:10.1111/jdv.16106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。